Recruiting
Dietitian-Nutritionist vs. Day Hospital in the Metabolic Control of Patients With Type 2 Diabetes
The present study aims to compare the effects on glycated hemoglobin (HbA1c) at 3 months of two care models in patients with type 2 diabetes referred due to poor glycemic control: a day hospital endocrinology care model versus a care model centered on follow-up by a dietitian-nutritionist.
ClinicalTrials.gov IDNCT07285330
PhaseNot Applicable
Enrollment140
SponsorConsorci Sanitari de l'Alt Penedès i Garraf
Age18 Years and older
SexALL
Conditions studied
Diabetes (DM)
About this study
The present study aims to compare the effects on glycated hemoglobin (HbA1c) at 3 months of two care models in patients with type 2 diabetes referred due to poor glycemic control: a day hospital endocrinology care model versus a care model centered on follow-up by a dietitian-nutritionist.
Interventions
- Other: Day Care Hospital — Clinical follow-up under the joint care of a nurse and an endocrinologist at Day Care Hospital
- Other: Nutritionist — Clinical follow-up with a dietitian-nutritionist and an endocrinologist at ambulatory care unit
Primary outcomes
- Glycate hemoglobin (three months after completion of the intervention)
Eligibility information
Inclusion Criteria:
* Patients with a diagnosis of type 2 diabetes (T2DM) referred to endocrinology due to poor metabolic control.
* Patients on insulin therapy
Exclusion Criteria:
* Referred from primary care for other reasons such as hypoglycemia.
* Patients with other types of diabetes mellitus or with uncertainty in diagnostic classification.
* Patients on rapid-acting insulin bolus therapy.
* Patients with acute decompensation of diabetes.
* Patients receiving corticosteroid treatment.
* Dependent individuals for activities of daily living (ADL) with a Barthel index score below 60 or with cognitive impairment.
* Language barrier.
Study locations
- Hospital de Vilafranca, Vilafranca del Penedès, Barcelona 08720 Spain
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.